Condition
Urogenital Neoplasms clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Urogenital Neoplasms clinical trials that are recruiting, at sites in 10 countries (most in United States (4), China (2), France (2)). By phase: Phase 2 (3), Phase 1/2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 10Countries
Newest Urogenital Neoplasms clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing a new method to predict response to immunotherapy in bladder cancer patients | — | Montpellier and 4 other locations | Recruiting | Dec 18, 2024 |
| Using 18F-Fluciclovine PET/CT to Predict Outcomes of Prostate Cancer Therapy | Phase 4 | Los Angeles, California | Recruiting | Nov 27, 2024 |
| CD70-targeted immunoPET Imaging of Kidney Cancer | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 8, 2024 |
| Using vorolanib for treating advanced kidney cancer | — | Nanjing, Jiangsu | Recruiting | Nov 6, 2024 |
| Combination of chemotherapy and immunotherapy for advanced penile cancer | Phase 2 | Leuven and 1 other locations | Recruiting | Apr 9, 2024 |
| Treatment with STAR0602 for advanced solid tumors | Phase 1/2 | Sacramento, California and 18 other locations | Recruiting | Oct 24, 2022 |
| Treatment for advanced prostate cancer using Lutetium-177 | Phase 1/2 | Miami, Florida and 20 other locations | Recruiting | Jun 10, 2022 |
| Understanding Urothelial and Rare Genitourinary Cancers | — | Bethesda, Maryland | Recruiting | Jun 11, 2021 |
| Combination of Pembrolizumab and Lenvatinib for Ovarian Cancer | Phase 2 | Ramat Gan | Recruiting | Aug 19, 2020 |
All recruiting trials (9)
-
Testing a new method to predict response to immunotherapy in bladder cancer patients
This study is testing a new test called SPHERTEST to see if it can help doctors figure out which bladder cancer patients are likely to respond well to immunotherapy after chemotherapy.
-
Using 18F-Fluciclovine PET/CT to Predict Outcomes of Prostate Cancer Therapy
This study is testing if special imaging can help predict how well a new prostate cancer treatment works for patients with advanced disease.
-
CD70-targeted immunoPET Imaging of Kidney Cancer
This study is testing a new imaging technique that uses a special marker to help doctors see kidney cancer more clearly.
-
Using vorolanib for treating advanced kidney cancer
This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.
-
Combination of chemotherapy and immunotherapy for advanced penile cancer
This study is testing a new treatment combining chemotherapy and immunotherapy for adults with advanced penile cancer to see if it helps them respond better to therapy and manage their disease.
-
Treatment with STAR0602 for advanced solid tumors
This study is testing a new treatment called STAR0602 to see if it can help people with advanced solid tumors by looking at how safe it is and how well it works.
-
Treatment for advanced prostate cancer using Lutetium-177
This study is testing a new treatment using Lutetium-177 for men with advanced prostate cancer that hasn't responded to other therapies to see how safe it is and how well it works.
-
Understanding Urothelial and Rare Genitourinary Cancers
This study is trying to learn more about urothelial and rare genitourinary cancers by gathering health information and samples from adults who have been diagnosed with these cancers.
-
Combination of Pembrolizumab and Lenvatinib for Ovarian Cancer
This study is testing a combination of two medications, pembrolizumab and lenvatinib, to see if they can help women with recurrent ovarian cancer that is sensitive to platinum-based treatments.
Related topics
Quick answers
How many Urogenital Neoplasms clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (4 trials), China (2 trials), France (2 trials), Belgium (2 trials), Netherlands (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.